{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-061153","form_type":"8-K/A","ticker":null,"cik":"0001760173","company_name":"SURGALIGN HOLDINGS, INC.","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.442968+00:00","generated_at":"2026-06-18T11:55:16.599169+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Surgalign updates restructuring: targets $30-35M savings, reports ~$82M revenue, sells Coflex/CoFix for $17M","bullets":["Inventory write-down of $12.5-15.5M in Q4 2022 due to product rationalization.","Workforce reduced by ~20% in December 2022; target cash savings of $30-35M in 2023 vs 2022.","Preliminary 2022 revenue ~$82M; year-end cash ~$16.3M.","Closed sale of Coflex/CoFix brands to Xtant Medical for $17M on March 1, 2023.","Product rationalization expected by mid-2023; ~70% of 2022 revenue from ~30% of brands."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-061153","json":"https://secwatch.observer/filing/0001193125-23-061153.json","markdown":"https://secwatch.observer/filing/0001193125-23-061153.md","text":"https://secwatch.observer/filing/0001193125-23-061153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523061153/0001193125-23-061153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523061153/d444936d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T11:55:16.599169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0c8038da930096f08fc5d4430891f2ebe431530","claim":"SURGALIGN HOLDINGS, INC. reported year ended December 30, 2022 results: revenue approximately $82.0 million. Guidance reaffirmed.","evidence_excerpt":"and Confirms its Prior 2022 Revenue Guidance Company on track to achieve target cash savings of $30—$35 million in 2023 vs 2022; expects to report 2022 revenue of approximately $82.0 million and end the year with a cash balance in excess of $16 million Deerfield, Ill., March 6, 2023 – Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523061153/0001193125-23-061153-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 30, 2022"},{"label":"Revenue","value":"approximately $82.0 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"e988e12e98419d981c7d3e68da9241dfcca678ee","claim":"SURGALIGN HOLDINGS, INC. announced a restructuring with charges of approximately $12.5—$15.5 million affecting companywide (reduction in force of approximately 20%).","evidence_excerpt":"underway and is expected to be finished by the middle of 2023. As part of this product rationalization, the Company expects to incur an inventory write down of approximately $12.5m - $15.5 million in its fourth quarter of 2022 for the period ended December 31, 2022. All other charges and costs disclosed within the November 9, 2022, Form 8-K have been","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523061153/0001193125-23-061153-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $12.5—$15.5 million"},{"label":"Affected area","value":"companywide"},{"label":"Headcount","value":"reduction in force of approximately 20%"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}